This HTML5 document contains 53 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
n9http://dx.doi.org/10.1046/
schemahttp://schema.org/
skoshttp://www.w3.org/2004/02/skos/core#
rdfshttp://www.w3.org/2000/01/rdf-schema#
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n11http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q71042841
rdf:type
wikibase:Item
schema:description
наукова стаття, опублікована в лютому 1996 artículu científicu espublizáu en febreru de 1996 wetenschappelijk artikel article scientifique publié en 1996 artikull shkencor i botuar më 01 shkurt 1996 scientific article published on 01 February 1996 im Februar 1996 veröffentlichter wissenschaftlicher Artikel
p:P577
wds:Q71042841-E907E21B-0A33-4F9E-87A8-15463E5D22E1
wdt:P577
1996-02-01T00:00:00Z
p:P2093
wds:Q71042841-64694BAF-51A5-4B0B-BF57-95781ECDADF8 wds:Q71042841-56913FE3-6C2E-44F0-B253-78B770A1B2CA wds:Q71042841-7B47BD05-4C1A-447C-921E-D6EA1C99EBA6 wds:Q71042841-026A7796-1F3A-4984-8542-66868BE8D107 wds:Q71042841-F84AFC9E-68EE-481C-948B-83CAAC40C959 wds:Q71042841-D6FE07C2-1F60-4CDE-B239-F79728782E0B
wdt:P2093
R Kotz A Zoubek F Stockenhuber R W Kurz C Wurnig E Schwameis
rdfs:label
Prevention of chemotherapy-induced anemia by the use of erythropoietin in patients with primary malignant bone tumors (a double-blind, randomized, phase III study) Prevention of chemotherapy-induced anemia by the use of erythropoietin in patients with primary malignant bone tumors (a double-blind, randomized, phase III study) Prevention of chemotherapy-induced anemia by the use of erythropoietin in patients with primary malignant bone tumors (a double-blind, randomized, phase III study)
skos:prefLabel
Prevention of chemotherapy-induced anemia by the use of erythropoietin in patients with primary malignant bone tumors (a double-blind, randomized, phase III study) Prevention of chemotherapy-induced anemia by the use of erythropoietin in patients with primary malignant bone tumors (a double-blind, randomized, phase III study) Prevention of chemotherapy-induced anemia by the use of erythropoietin in patients with primary malignant bone tumors (a double-blind, randomized, phase III study)
schema:name
Prevention of chemotherapy-induced anemia by the use of erythropoietin in patients with primary malignant bone tumors (a double-blind, randomized, phase III study) Prevention of chemotherapy-induced anemia by the use of erythropoietin in patients with primary malignant bone tumors (a double-blind, randomized, phase III study) Prevention of chemotherapy-induced anemia by the use of erythropoietin in patients with primary malignant bone tumors (a double-blind, randomized, phase III study)
p:P50
wds:Q71042841-6263C55A-CD96-44EA-8D3D-5076B8A310FB
wdt:P50
wd:Q15842070
p:P1476
wds:Q71042841-1A14173F-988E-4248-AF06-F2BC01060AC2
wdt:P1476
Prevention of chemotherapy-induced anemia by the use of erythropoietin in patients with primary malignant bone tumors (a double-blind, randomized, phase III study)
p:P304
wds:Q71042841-7BBE66CD-D940-4645-9396-B87A138E8ED3
wdt:P304
155-159
p:P31
wds:Q71042841-0C9AD96E-3CAA-453C-8E48-6F156B34A7C0
wdt:P31
wd:Q13442814
p:P921
wds:Q71042841-85E40DE5-2A3A-4012-BE37-58F01A50ED66
wdt:P921
wd:Q974135
p:P698
wds:Q71042841-15E83A39-910F-4A81-9410-6965DB925540
wdtn:P698
n11:8614967
wdt:P698
8614967
p:P1433
wds:Q71042841-22B1C078-ABE7-44EA-A172-BF4837238487
wdt:P1433
wd:Q15758500
p:P433
wds:Q71042841-12E9F235-550F-47DD-9632-6862240648E9
p:P478
wds:Q71042841-6A1EC9B5-5804-4F27-B943-F2649BC42442
wdt:P433
2
wdt:P478
36
p:P356
wds:Q71042841-4953070D-CF86-40C6-A6AA-810ED0ABBF33
wdtn:P356
n9:J.1537-2995.1996.36296181929.X
wdt:P356
10.1046/J.1537-2995.1996.36296181929.X